Hammad Bajwa, M.D.
Rheumatology Physician in Edina, Minnesota.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,181 in Rheumatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Hammad Bajwa, M.D. reported a CMS MIPS final score of 95.2/100 - above the 83.1 national average - and filed 3,196 Medicare Part D claims in 2023.
- 95.2/100
- MIPS score · +12 vs avg
- 3K
- Part D claims, 2023
- 84%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Hammad Bajwa, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
95 Top 21% higher than 79% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Hammad Bajwa, M.D. sits
This provider among rheumatology physician peers
Across the 2,181 rheumatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Hammad Bajwa, M.D. writes more Part D claims than 74% of them and scores higher on MIPS quality than 79% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one rheumatology physician peer from a representative sample of 60; the gold marker is Hammad Bajwa, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Hammad Bajwa, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Hammad Bajwa, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Minnesota
How Rheumatology Physician compares to other specialties among Minnesota providers
Rheumatology Physician ranks #104 among Minnesota's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Minnesota provider total, by primary NUCC taxonomy. The highlighted bar is Rheumatology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Hammad Bajwa, M.D.'s 2023 MIPS final score plotted against the Rheumatology Physician national average
- MIPS Final Score
- 95.2/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Rheumatology Physician) - 95.2/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Rheumatology Physician US NPIs
95.2/100 MIPS final score - 12.1 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Rheumatology Physician. Quality dim: 91.3.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Hammad Bajwa, M.D. appears in the CMS NPPES registry as a Rheumatology Physician provider holding M.D. credentials at 7600 FRANCE AVE S STE 5100, Edina, MN, 55435, with a listed phone of (952) 893-1959. NPI 1790838753 was issued on 01/20/2007.
Medicare Part D records for calendar year 2023 show 3,196 prescription claims written by this provider, covering 532 Medicare beneficiaries and totaling roughly $1.3 million in drug spend, split 16% brand-name and 84% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 95.2/100 for the 2023 performance year (Quality 91.3), compared with the national average of 83.1.
Rheumatology Physician is a mid-sized specialty nationwide, with 6,181 enrolled providers across 52 states and an average of 2,054 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1790838753 |
|---|---|
| Specialty | Rheumatology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 01/20/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Hammad Bajwa, M.D.'s current license status, disciplinary history, and board certifications with the Minnesota Board of Medical Practice in Minnesota before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1790838753 is the unique 10-digit identifier CMS uses to link Bajwa across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Hammad Bajwa, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
16% brand-name claims vs 84% generic, on 3,196 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 7,789
- Total Day Supply
- 230,990
- Brand vs Generic
- 16% brand / 84% generic
- Brand Drug Cost
- $1.1M
- Generic Drug Cost
- $175K
Patient Demographics
- Average Patient Age
- 73.7 years
- Avg HCC Risk Score
- 1.43
- Gender Split
- 73% female / 27% male
- Age Distribution
- <65: 48, 65-74: 244, 75-84: 185, 85+: 55
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Hammad Bajwa, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Methotrexate
Methotrexate
781 claims
- Prednisone
Prednisone
740 claims
- Hydroxychloroquine…
Hydroxychloroquine Sulfate
575 claims
- Leflunomide 223
Leflunomide
223 claims
- Sulfasalazine Dr 147
Sulfasalazine Dr
147 claims
- Sulfasalazine 142
Sulfasalazine
142 claims
- Allopurinol 119
Allopurinol
119 claims
- Folic Acid 54
Folic Acid
54 claims
| Drug | Claims |
|---|---|
| Methotrexate Methotrexate Sodium | 781 |
| Prednisone | 740 |
| Hydroxychloroquine Sulfate | 575 |
| Leflunomide | 223 |
| Sulfasalazine Dr Sulfasalazine | 147 |
| Sulfasalazine | 142 |
| Allopurinol | 119 |
| Folic Acid | 54 |
| Mycophenolate Mofetil | 44 |
| Humira Pen Adalimumab | 41 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Rheumatology Physician Overview
How Hammad Bajwa, M.D. fits within the Rheumatology Physician landscape nationally.
Hammad Bajwa, M.D.'s 3,196 claims are above the specialty average of 2,054.
Nearby Rheumatology Physician Providers in Minnesota
Other clinicians with the same primary specialty enrolled in Minnesota, drawn from the same CMS NPPES roster as Bajwa.
Compare Rheumatology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Minnesota medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Rheumatology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Minnesota
Frequently Asked Questions
What is Hammad Bajwa, M.D.'s specialty? ▼
How much does Hammad Bajwa, M.D. prescribe under Medicare Part D? ▼
What is Hammad Bajwa, M.D.'s Medicare quality score? ▼
Where is Hammad Bajwa, M.D. located? ▼
What is Hammad Bajwa, M.D.'s NPI number? ▼
Does Hammad Bajwa, M.D. prescribe more brand-name or generic drugs? ▼
How many Rheumatology Physician providers are there in the US? ▼
What drugs does Hammad Bajwa, M.D. prescribe most often? ▼
Does Hammad Bajwa, M.D. accept Medicare? ▼
How can I verify Hammad Bajwa, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology